A Possible American Treatment for Coronavirus Recovers European Shares

European Shares Recovers as America Approves a Possible Treatment for Coronavirus   European stocks opened the first trading sessions of the week with good gains, amid a state of optimism after the American authorities announced on Sunday night the approval of a possible treatment for the Corona virus, while the share of the (BT) group gained attention after it jumped strongly as the company took steps toward potential takeover of the company. European different markets opened the week's trading with optimism, after hopes of finding a cure for coronaviruse were renewed, Sunday night, as The US Food and Drug Administration has announced that it has given approval for the emergency use of EUA as a possible treatment for Coronavirus, which uses the method of transferring blood plasma from patients who have recovered from the virus, to patients who are on recovery beds. At 7:40 GMT, the German DAX index is up to 1.4%, while the Paris CAC 40 index is up to 1.8%. On the nearby bank, the London FTSE 100 index  is up to 1.4%. On the other hand, shares of AstraZeneca (LON: AZN) (NYSE: AZN)_the company that will develop the vaccine_ jumped 2.2%. Shares of BT Group (LON: BT) jumped 6.9% after British Sky News reported that the TelecomGiant had approached Goldman Sachs Investment Bank with the aim of updating its defense strategy towards potential buyers. Elsewhere, Bonzel (OTC: BZLFY) stock rose 4% after posting a pre-tax earnings hike for the first half of 2020. Conversely, Aud Mutual (LON: OMU) plunged 1.5% after the South African insurer, whose stock is trading in London, recorded a loss in the first half due to the Corona pandemic, which pushed the country's economy into a deep recession.   You might also be interested in:

Stock Market Has Started New Week With Increase